Annu Kapoor’s Heart of Gold in Discomfort, treated in Sir Ganga Ram

New Delhi: Singer, Encyclopaedia of Bollywood singers, vetran actor, host, dancer and whatnots Annu Kapoor ( Annu Madan Lal Kapoor) felt discomfort in his chest and was rushed to Sir Ganga Ram hospital. Reportedly, he suffered from chest pain. He was discherged from the hospital in a stable condition January 29th.

According to Dr Ajay Swaroop , Chairman (Board of Management , Sir Ganga Ram Hospital “Mr Annu Madan Lal Kapoor who was admitted to Sir Ganga ram hospital on 26 th January early morning with complaints of chest discomfort has been discharged today .*He underwent treatment by Cardiology team comprising Dr JPS Sawhney / Dr Rajneesh jain/ Dr Rajiv Passey /Dr BS vivek and Dr Sushant Wattal.*

As per Dr Rajneesh jain Co director Cath lab and Head of the unit , under whom he was admitted , Mr Annu Kapoor has been discharged today in a stable condition. He has been darling of audiences because of his warmth and heartful interaction.

Aged 66,  versatile and exuberant  Annu Kapoor has heart of gold. For him, age has always been just a number.

Related Posts

Yashoda Medicity’s Medical Tourism Footprint widens with Republic of Kazakhstan on Board

MOU signed for Patient Referrals, Tele-Consultations and Specialist Healthcare Collaboration Delhi NCR: Unveiled not long ago, Yashoda Medcity’s reputation as being best in class healthcare facility in Delhi NCR has…

Liver enters FATal Straits in India, AIIMS Experts red flag

In first for India, World Congress of Gastroenterology comes calling to asses GI disease burden New Delhi: As global and national burden of digestive diseases reach a critical crossroads, World…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A

US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A

Technology and accessibility are key to growth of advanced treatment of heart diseases, says expert

Technology and accessibility are key to growth of advanced treatment of heart diseases, says expert

Puresta launches EVERQ, AI-powered skin-health platform

Puresta launches EVERQ, AI-powered skin-health platform

Stem cell therapy for autism only in approved clinical trials: Centre

Stem cell therapy for autism only in approved clinical trials: Centre